You are here

Japan

Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout

Endpoints

Thu, 07/5/18 - 10:50 am

AstraZeneca wins speedy approvals for cancer drugs in Japan

Yahoo/Reuters

Mon, 07/2/18 - 09:23 am

What to Expect for AstraZeneca in Fiscal 2018

Market Realist

Sat, 06/9/18 - 10:11 am

Astellas to pay Aquinox $25M upfront for regional rights to phase 3 inflammatory pain drug

Fierce Biotech

Thu, 05/10/18 - 09:32 am

Aquinox Pharmaceuticals

SHIP1 activator

Myriad’s breast cancer diagnostic wins approval in Japan

Drug Delivery Business News

Mon, 04/2/18 - 09:27 am

Myriad Genetics

Bracanalysis Diagnostic System

Japan approves Novo Nordisk’s once-weekly Type II diabetes drug

Drug Delivery Business News

Fri, 03/23/18 - 09:45 am

type 2 diabetes

Reimbursement Trends for Medical Devices in Japan

Medical Devices and Diagnostics Industry

Tue, 03/6/18 - 09:28 am

Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019

Fierce Pharma

Wed, 02/28/18 - 11:14 am

Shionogi, Roche get their first approval for the next big thing in fighting the flu

Endpoints

Fri, 02/23/18 - 09:28 am

Why Thailand is an Untapped Medtech Opportunity

Medical Devices and Diagnostics Industry

Mon, 02/12/18 - 09:08 am

medical tourism

Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma

Endpoints

Sat, 01/20/18 - 02:56 pm

Cancer Space Update: New Regulatory Status for 3 Major Drugs

Yahoo/Zacks.com

Fri, 01/5/18 - 05:33 pm

Seattle Genetics

Bayer AG taps PeptiDream in billion-dollar deal

Endpoints

Mon, 11/20/17 - 11:10 am

FDA, EMA and PMDA Plot Harmonized Path for Antibiotics

RAPS.org

Sat, 11/18/17 - 09:46 am

Why Do Alzheimer’s Drugs Fail? Japanese Researchers May Have Found an Answer

Xtalks

Thu, 10/26/17 - 09:35 pm

Alzheimer's disease

As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing

Fierce Pharma

Thu, 10/5/17 - 06:16 pm

performance-based pricing

AstraZeneca's latest respiratory win could spur Bevespi approvals in China, Japan

Fierce Pharma

Wed, 09/27/17 - 11:29 am

Cytokinetics inches forward with heart failure program

BioPharma Dive

Thu, 08/3/17 - 10:57 am

Omecamtiv Mecarbil

Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula

Endpoints

Thu, 07/27/17 - 09:52 am

Resolute Onyx drug-eluting stent launches in Japan

Drug Delivery Business News

Sun, 07/9/17 - 11:37 am

drug-eluting stents

Pages